Mercy Hospital & Health Services Contact Us
MyChart
About Mercy
Join Our Team
set font size large set font size medium set font size small
email this page print this page
Roche Alecardio Banner

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Sponsored by Hoffmann-La Roche, July 2010


Purpose


This double-blind, parallel, two-arm study will evaluate the potential to reduce cardiovascular risk, the tolerability and long-term safety profile of aleglitazar compared to placebo on top of standard care in patients with recent acute coronary syndrome (ACS) and type 2 diabetes mellitus. Patients will be randomized to receive either aleglitazar or placebo once daily as oral doses. The study will last until at least 950 events occur, but time on study treatment will be for at least 2.5 years. The target sample size is 6000-7000 patients. 

ConditionInterventionPhase
Diabetes Mellitus, Type 2Drug: Aleglitazar
Drug: Placebo
Phase III

separator

Eligibility
 

Ages Eligible for Study:
Genders Eligible for Study:
Accepts Healthy Volunteers:
18 Years and older
Both
No

Criteria


Inclusion Criteria:
  • Adults >18 years of age
  • Type 2 diabetes mellitus
  • Hospitalization for ACS event and randomization 2-6 weeks after day of hospitalization
Exclusion Criteria:
  • Estimated glomerular filtration rate <45mL/min/1.73m2
  • Concomitant treatment with a thiazolidinedione and/or fibrate
  • Triglycerides >400 mg/dL
  • Anaemia
  • Symptomatic congestive heart failure classified as NYHA class II-IV
separator

Contacts and Locations


Physicians:
Ameer Kabour, MD
Raza Hashmi, MD
Tarif Kanaan, MD
Mohammad Alkhateeb, MD

Coordinators:
Michelle Hickam, RN, BSN
Brenda Hoagland, RN, CCRC
Julie Neidhardt, RN, BSN

Please contact us at 419-251-4919 for further information about this study.
www.mercyweb.org

Mother Touched by Compassionate Care
Toledo, Ohio - January is a difficult month for Caryn K. On Jan. 17, 2005, she gave birth to a ...
Read the full story >

Share Your Moment! >

follow us online
facebook youtube


Contact us
Home  |  Sitemap

Disclaimer & Terms of Use  |  Privacy Statement  |  Notice of Privacy Practices
Copyright ©2013 Mercy. Last modified 3/18/2011